Galecto Inc said on Tuesday it will dicontinue development of its lung disease treatment after it failed to meet its primary goal in a mid-stage study.
https://finance.yahoo.com/news/galecto-discontinue-development-lung-disease-113556937.html
Galecto Inc said on Tuesday it will dicontinue development of its lung disease treatment after it failed to meet its primary goal in a mid-stage study.
https://finance.yahoo.com/news/galecto-discontinue-development-lung-disease-113556937.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.